Credit Suisse Group set a €84.00 ($97.67) price objective on Gerresheimer (ETR:GXI) in a research report sent to investors on Thursday, April 11th, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock.
A number of other analysts also recently weighed in on GXI. JPMorgan Chase & Co. set a €49.50 ($57.56) target price on shares of Gerresheimer and gave the company a sell rating in a research report on Wednesday, January 2nd. Deutsche Bank set a €86.00 ($100.00) target price on shares of Gerresheimer and gave the company a buy rating in a research report on Tuesday, January 15th. Berenberg Bank set a €81.00 ($94.19) target price on shares of Gerresheimer and gave the company a buy rating in a research report on Thursday, January 31st. Goldman Sachs Group set a €65.00 ($75.58) target price on shares of Gerresheimer and gave the company a neutral rating in a research report on Monday, February 11th. Finally, Independent Research set a €66.00 ($76.74) target price on shares of Gerresheimer and gave the company a neutral rating in a research report on Thursday, February 14th. Three analysts have rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the stock. Gerresheimer currently has a consensus rating of Hold and a consensus price target of €69.17 ($80.43).
ETR:GXI traded up €0.90 ($1.05) on Thursday, reaching €68.70 ($79.88). 58,923 shares of the stock traded hands, compared to its average volume of 140,925. The company has a market capitalization of $2.16 billion and a PE ratio of 12.04. The company has a debt-to-equity ratio of 68.19, a quick ratio of 0.51 and a current ratio of 0.78. Gerresheimer has a 1-year low of €51.10 ($59.42) and a 1-year high of €80.25 ($93.31).
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Further Reading: Put Option
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.